Cargando…
Statins can benefit patients with primary membranous nephropathy on venous thromboembolism
OBJECTIVE: The aim of this study was to investigate the role of prophylactic use of statin in venous thromboembolism (VTE) in patients with primary membranous nephropathy (PMN). METHODS: A total of 734 patients with PMN were consecutively enrolled in this retrospective study. 564 patients had receiv...
Autores principales: | Zou, Peimei, Li, Hang, Cai, Jianfang, Chen, Zhenjie, Li, Chao, Li, Xuewang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889158/ https://www.ncbi.nlm.nih.gov/pubmed/33583321 http://dx.doi.org/10.1080/0886022X.2021.1879853 |
Ejemplares similares
-
The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy
por: Zou, Peimei, et al.
Publicado: (2019) -
The role of dyslipidemia and statins in venous thromboembolism
por: Ray, Joel G, et al.
Publicado: (2001) -
Risk factors of venous thromboembolism in anti-PLA2R-positive and negative primary membranous nephropathy
por: Wu, Henry H L, et al.
Publicado: (2022) -
Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021) -
Bilateral Renal Vein Thrombosis in Membranous Nephropathy: Hypoalbuminemia Predictive of Venous Thromboembolism in Nephrotic Syndrome
por: Casey, Derek, et al.
Publicado: (2022)